ユタにおけるがん（全種類）の臨床試験
ユタ内の拠点で、がん（全種類）に関する39件の研究が参加者を募集しています。
ユタ内の都市
公式研究テキスト（英語）
A Clinical Study of Calderasib (MK-1084) in People With Advanced Solid Tumors (MK-1084-014)
- START Mountain Region ( Site 1106), West Valley City
被験者募集中第2相
18歳以上 · 全性別 · 2026/10/01更新 · NCT07209111A Study of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01D/LIGHTBEAM-U01)
- Intermountain - Primary Children's Hospital ( Site 4014), Salt Lake City
被験者募集中第1/2相
1 Month – 17 Years · 全性別 · 2026/09/25更新 · NCT07630974SAFE.AI: Developing and Testing an AI-based Hybrid Chatbot for Financial Empowerment in Rural Cancer Care
- Huntsman Cancer Institute/ University of Utah, Salt Lake City
被験者募集中
18歳以上 · 全性別 · 2026/09/25更新 · NCT07410689A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
- Utah Cancer Specialists Cancer Center - Medical Oncology, Salt Lake City
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/24更新 · NCT06901531TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
- Cedar City Hospital, SW Cancer Clinic, Sandra Maxwell Cancer Center, Cedar City
- Intermountain Healthcare, Salt Lake City
- Dixie Regional Medical Center-River Road Campus, St. George
被験者募集中第2相
12歳以上 · 全性別 · 2026/09/22更新 · NCT02693535Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
- University of Utah - Huntsman Cancer Institute, Salt Lake City
- Intermountain Healthcare - LDS Hospital, Salt Lake City
被験者募集中第2/3相
全年齢 · 全性別 · 2026/09/18更新 · NCT03435796A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01)
- Intermountain - Primary Children's Hospital ( Site 3014), Salt Lake City
被験者募集中第1/2相
1 Month – 17 Years · 全性別 · 2026/09/17更新 · NCT06941272RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- Cedar Clinical Research Inc., Draper
被験者募集中第2相
18歳〜80歳 · 全性別 · 2026/09/15更新 · NCT07002034(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
- Huntsman Cancer Institute - University of Utah Health, Salt Lake City
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/15更新 · NCT04996875A Study to Assess Adverse Events and Change in Disease Activity of Oral Surzetoclax Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM)
- Huntsman Cancer Institute /ID# 271618, Salt Lake City
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/14更新 · NCT06953960A Study to Investigate Safety and Effectiveness of Tacabrutideg (BGB-16673) in Combination With Other Agents in Participants With Relapsed or Refractory B-Cell Malignancies
- Huntsman Cancer Institute, Salt Lake City
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/11更新 · NCT06634589A Phase 1/1b Study of IAM1363 in HER2 Cancers
- START Mountain Region, West Valley City
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/09更新 · NCT06253871A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer
- Community Cancer Trials of Utah, Ogden
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/04更新 · NCT07169851Project: Every Child for Younger Patients With Cancer
- Primary Children's Hospital, Salt Lake City
被験者募集中観察研究
25歳以下 · 全性別 · 2026/08/25更新 · NCT02402244A Study of REC-1245 in Participants With Unresectable, Locally Advanced, or Metastatic Cancer
- START Mountain Region, West Valley City
被験者募集中第1/2相
12歳以上 · 全性別 · 2026/08/20更新 · NCT06678659Abatacept in Immune Checkpoint Inhibitor Myocarditis
- University of Utah, Salt Lake City
被験者募集中第3相
18歳以上 · 全性別 · 2026/08/20更新 · NCT05335928Two Part Study of Nenocorilant Combined With Nivolumab in Patients With Advanced Solid Malignancies
- Site 02, West Valley City
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/08/19更新 · NCT07276373A Study of mRNA-4106 or mRNA-4200 Administered Alone or in Combination With Anti-Cancer Agents in Participants With Solid Tumors
- START Mountain Region, West Valley City
被験者募集中第1相
18歳以上 · 全性別 · 2026/08/10更新 · NCT06880549Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
- University of Utah Sugarhouse Health Center, Salt Lake City
- Huntsman Cancer Institute/University of Utah, Salt Lake City
- South Jordan Health Center, South Jordan
被験者募集中第3相
18歳以上 · 全性別 · 2026/08/07更新 · NCT06580314A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Multiple Myeloma Receiving T Cell Engaging Bi/Tri-specific Antibodies Intravenously (IV)/Subcutaneously (SC) Alone or in Combinations
- Huntsman Cancer Institute /ID# 272575, Salt Lake City
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/07/21更新 · NCT06892522A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
- Huntsman Cancer Institute, University of Utah, Salt Lake City
- START Mountain Region, LLC., West Valley City
被験者募集中第1相
18歳以上 · 全性別 · 2026/07/15更新 · NCT06657144Sun Exposure and Activities After Skin Cancer: Optimization of mHealth Interventions
- Huntsman Cancer Institute at The University of Utah, Salt Lake City
被験者募集中
18歳以上 · 全性別 · 2026/07/10更新 · NCT07556380First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
- START Mountain Region, West Valley City
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/07/07更新 · NCT05768139A Study to Evaluate the Safety,Tolerability, Pharmacokinetics and Clinical Activity of Mocertatug Rezetecan for Injection in Participants With Advanced Solid Tumors (BEHOLD-1)
- GSK Investigational Site, West Valley City
被験者募集中第1相
18歳以上 · 全性別 · 2026/06/25更新 · NCT06431594Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI
- VA Salt Lake City Health Care System, Salt Lake City, UT, Salt Lake City
被験者募集中
18歳〜75歳 · 全性別 · 2026/06/17更新 · NCT05486572Galleri® in the Medicare Population.
- HCA Healthcare St. Marks, Salt Lake City
被験者募集中健康なボランティア歓迎
50歳以上 · 全性別 · 2026/05/22更新 · NCT05673018A Study of GSK5764227 in Participants With Advanced Solid Tumors (EMBOLD)
- GSK Investigational Site, West Valley City
被験者募集中第1相
18歳以上 · 全性別 · 2026/05/22更新 · NCT06551142Heuristic Tool To Improve Symptom Self-Management in Adolescents and Young Adults With Cancer
- University of Utah Huntsman Cancer Institute (HCI), Salt Lake City
- University of Utah Primary Children's Hospital, Salt Lake City
被験者募集中
15歳〜29歳 · 全性別 · 2026/05/22更新 · NCT05958316I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
- Huntsman Cancer Institute, University of Utah, Salt Lake City
被験者募集中第2相
18歳以上 · 全性別 · 2026/05/06更新 · NCT01042379Safety, Pharmacokinetics, and Clinical Activity of LP-284 in Adult Patients With Relapsed or Refractory Lymphomas and Solid Tumors
- START Mountain Region, West Valley City
被験者募集中第1相
18歳以上 · 全性別 · 2026/05/04更新 · NCT06132503Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
- George E. Wahlen Department of Veterans Affairs Medical Center, Salt Lake City
被験者募集中
18歳以上 · 全性別 · 2026/04/30更新 · NCT05297734Improving Health Insurance Literacy Among Young Adult Cancer Survivors
- Intermountain Health, Murray
- University of Utah, Salt Lake City
被験者募集中
26歳〜45歳 · 全性別 · 2026/04/28更新 · NCT05829070CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
- Huntsman Cancer Institute, University of Utah, Salt Lake City
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/04/16更新 · NCT03328078Enhancing Motivation to Quit Smoking Via Self-Help Intervention Targeted to Cancer Type
- Huntsman Cancer Institute, Salt Lake City
被験者募集中
18歳以上 · 全性別 · 2025/11/26更新 · NCT06484179Dose-escalation Study to Assess Safety and Pharmacokinetics of Nab-Sirolimus in Patients With Locally Advanced or Metastatic Solid Tumors and Moderate Liver Impairment
- START Mountain Region, West Valley City
被験者募集中第1相
18歳以上 · 全性別 · 2025/11/13更新 · NCT05661461Childhood Cancer Predisposition Study (CCPS)
- Primary Children's Hospital, Salt Lake City
被験者募集中観察研究
全年齢 · 全性別 · 2025/10/29更新 · NCT04511806SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Salt Lake City
被験者募集中観察研究
全年齢 · 全性別 · 2025/10/28更新 · NCT03452774Tempus CRC Surveillance Study: A ctDNA Biomarker Profiling Study of Patients With CRC Using NGS Assays
- Utah Cancer Specialists, Salt Lake City
被験者募集中観察研究
18歳以上 · 全性別 · 2025/05/06更新 · NCT05234177Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
- Intermountain Medical Center, Murray
- Huntsman Cancer Institute (The University of Utah), Salt Lake City
被験者募集中
18歳以上 · 全性別 · 2024/11/27更新 · NCT03860883ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。